Loss of tumour suppressor genes Pten and Rb1 is common in prostate cancer10, and genetically engineered mouse models of Pten loss and combined Pten;Rb1 loss recapitulate key features of prostate adenocarcinoma27. This evidence concerns the gene PTEN and neoplasm.